Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Strategic Perspectives : Cancer Adjunct Therapies' returned 4 results - Page 1 of 1  FEATURED RESULTS Antibody Drug Target Atlas in Oncology Drug Delivery in Cancer - Technologies, Markets and Companies Cancer Diagnostic Testing World Markets Cancer and its Management, 6th Edition Drug Delivery in Cancer - Technologies, Markets and Companies   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Nov 2011, Pages: 906 of described drug target strategies (total) of peptide drugs belongs to Cancer Research Technology (7), Affymax (4), Esperance Pharmaceuticals (3) and Raptor Pharmaceutical (3). - From an indication perspective Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline   Bioseeker, June 2010, Pages: 596 . This report identifies the competitive terrain for cancer therapeutic peptides to be wide open from a compound perspective and the opportunity for peptide drugs to challenge other biologicals such as antibodies Pharmaceuticals - Global Outlook   Global Industry Analysts, Inc., Sep 2008, Pages: 425 special preludes to major market segments, such as, Prescription Drugs, Blockbuster Drugs, Anti-Depressants, COPD, Cholesterol Drugs, CNS Drugs, Cardiovascular Drugs, Cancer Drugs, Attention Deficit Immunoassay Systems - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2010, Pages: 589 of the New Game... - Changing Scene for Immunodiagnostic Testing... - Laboratory Automation on Rise - Market for Adjunctive Therapies to Grow Fast 3. CONCEPTUAL OVERVIEW II-13 - Immunoassays Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network